MNPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Monopar Therapeutics Inc (MNPR) does not present a strong buy opportunity for a beginner, long-term investor at this time. While the stock has shown a positive regular market change of 4.78% and a bullish MACD, the RSI indicates an overbought condition, suggesting limited immediate upside potential. Additionally, there are no significant trading trends, news catalysts, or financial data to support a strong buy decision. The lack of Intellectia Proprietary Trading Signals further supports a cautious approach.
The MACD is positive and expanding (0.37), indicating bullish momentum. However, the RSI is at 83.403, signaling an overbought condition. Moving averages are converging, and the stock is trading near resistance levels (R1: 66.253, R2: 68.66), suggesting limited upside potential in the short term.
Bullish MACD and recent regular market price increase of 4.78%.
RSI indicates overbought conditions, no significant trading trends, no news catalysts, and no recent congress trading data.
No financial data available for analysis.
No analyst rating or price target changes available.
